GAS2 is reportedly involved in the disease transformation of CML 52 and exhibits an opposite effect on the inhibition or emergency granulopoiesis termination roles of ICSBP for leukaemia.53, 54. The gene discussed is IRF8; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.